Abbott Laboratories
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Abbott Laboratories's balance sheet done over the years? Its assets were worth $73,214,000,000 last year, which is less than in the previous period. 47% of Abbott Laboratories’s total assets is currently financed by debt. Its liabilities reached the amount of $34,387,000,000, which means an decrease by -8% compared compared to last year.
Debt to Assets
| 2014 | 41275000000 | 19.63B | 47.57% |
|---|---|---|---|
| 2015 | 41247000000 | 19.92B | 48.3% |
| 2016 | 52666000000 | 31.94B | 60.66% |
| 2017 | 76250000000 | 45.15B | 59.22% |
| 2018 | 67173000000 | 36.45B | 54.26% |
| 2019 | 67887000000 | 36.58B | 53.89% |
| 2020 | 72548000000 | 39.54B | 54.51% |
| 2021 | 75196000000 | 39.17B | 52.09% |
| 2022 | 74438000000 | 37.53B | 50.42% |
| 2023 | 73214000000 | 34.38B | 46.97% |
ABT.SW Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 6.89B | 9.88B | 9.79B | 6.83B | 3.86B | 3.84B | 9.40B | 18.62B | 5.00B | 4.06B |
Short term investments | 383M | 288M | 450M | 310M | 280M | 242M | 203M | 155M | 1.12B | 397M |
Net receivables | 6.56B | 8.88B | 6.48B | 6.41B | 5.42B | 5.18B | 5.24B | 3.24B | 3.41B | 3.58B |
Inventory | 6.57B | 6.17B | 5.15B | 5.01B | 4.31B | 3.79B | 3.60B | 2.43B | 2.59B | 2.64B |
Other current assets | 2.25B | 2.66B | 2.34B | 1.86B | 1.78B | 1.56B | 1.68B | 2.31B | 2.01B | 2.86B |
Total current assets | 22.67B | 25.22B | 24.23B | 20.44B | 15.66B | 14.63B | 20.14B | 26.77B | 14.15B | 15.26B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 11.27B | 9.16B | 8.95B | 9.02B | 8.03B | 7.56B | 7.60B | 5.70B | 5.73B | 5.93B |
Goodwill | 23.67B | 22.79B | 23.23B | 23.74B | 23.19B | 23.25B | 24.02B | 7.68B | 9.63B | 10.06B |
Intangible assets | 8.81B | 10.45B | 12.73B | 14.78B | 17.02B | 18.94B | 21.47B | 4.53B | 5.56B | 6.19B |
Long term investments | 485M | 766M | 816M | 821M | 883M | 897M | 883M | 2.94B | 4.04B | 229M |
Other non-current assets | 6.28B | 0 | 0 | 0 | 0 | 17M | 176M | 2.75B | 2M | 1.93B |
Total non-current assets | 50.54B | 49.21B | 50.95B | 52.10B | 52.22B | 52.54B | 56.10B | 25.89B | 27.09B | 26.01B |
Total assets | 73.21B | 74.43B | 75.19B | 72.54B | 67.88B | 67.17B | 76.25B | 52.66B | 41.24B | 41.27B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 0 | 305M | 0 | 3.91B | 4.60B | 4.35B |
Short term debt | 1.32B | 2.25B | 754M | 220M | 1.47B | 207M | 714M | 1.32B | 3.13B | 4.43B |
Total current liabilities | 13.84B | 15.48B | 13.10B | 11.90B | 10.86B | 9.01B | 8.91B | 6.66B | 9.18B | 10.53B |
| Non-current liabilities: | ||||||||||
Long term debt | 14.54B | 15.46B | 18.25B | 19.42B | 17.41B | 19.35B | 27.21B | 20.68B | 5.87B | 3.40B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 5.43B | 5.58B | 3.68B | 3.68B | 3.94B | 3.98B | 6.86B | 4.25B | 2.62B | 2.71B |
Total non-current liabilities | 20.54B | 22.04B | 26.06B | 27.63B | 25.72B | 27.43B | 36.24B | 25.28B | 10.73B | 9.10B |
Total liabilities | 34.38B | 37.53B | 39.17B | 39.54B | 36.58B | 36.45B | 45.15B | 31.94B | 19.92B | 19.63B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |